Page 100 - 80_03
P. 100
La
respuesta
a
darbepoetina--alfa…
11.
Drueke,
TB.;
Locatelli,
F.;
Clyne,
N.;
Eckardt,
KU.;
Macdougall,
IC.;
Tsakiris,
D.;
et
al.
Normalization
of
hemoglobin
level
in
patients
with
chronic
kidney
disease
and
anemia.
N.
Engl.
J.
Med.16,
2071--2084
(2006).
12.
Rattanasompattikul,
M.;
Molnar,
MZ.;
Zaritsky,
JJ.;
Hatamizadeh,
P.;
Jing,
J.;
Norris,
KC.;
et
al.
Association
of
malnutrition--inflammation
complex
and
responsiveness
to
erythropoiesis--
stimulating
agents
in
long--term
hemodialysis
patients.
Nephrol.
Dial.
Transplant.28,1936--
45
(2013).
13.
Barany,P.;
Inflammation,
serum
C--reactive
protein,
and
erythropoietin
resistance.
Nephrol.
Dial.
Transplant.16,
224--227
(2001).
14.
Hodges,
VM.;
Rainey,
S.;
Lappin,
TR.;
Maxwell,
AP.;
Pathophysiology
of
anemia
and
erythrocytosis.
Crit.
Rev.
Oncol.
Hematol.64,139--158
(2007).
15.
Cooper,
AC.;
Mikhail,
A.;
Lethbridge,
MW.;
Kemeny,
DM.;
Macdougall,
IC.;Increased
expression
of
erythropoiesis
inhibiting
cytokines
(IFN--gamma,
TNF--alpha,
IL--10,
and
IL--
13)
by
T
cells
in
patients
exhibiting
a
poor
response
to
erythropoietin
therapy.
J.
Am.
Soc.
Nephrol.14,
1776--1784
(2003).
16.
Macdougall,
IC.;
Cooper,
AC.;Hyporesponsiveness
to
erythropoietic
therapy
due
to
chronic
inflammation.
Eur.
J.
Clin.
Invest.
35,
32--35(2005).
17.
Perez,
GR.;
Gonzalez,
PE.;
Ceballos,
F.;
Escallada,
CR.;
Gomez--Reino,
MI.,
Martin--Rabadan,
P.;
et
al.
[Guidelines
for
quality
management
of
dialysis
solutions].
Nefrologia.
24
Suppl
2,
1--
42
(2004).
18.
Rattanasompattikul,
M.;
Feroze,
U.;
Molnar,
MZ.;
Dukkipati,
R.;
Kovesdy,
CP.,
Nissenson,
AR.;
et
al.
Charlson
comorbidity
score
is
a
strong
predictor
of
mortality
in
hemodialysis
patients.
Int.
Urol.
Nephrol.44,
1813--1823
(2012).
19.
Gunnell,
J.;
Yeun,
JY.;
Depner,
TA.;
Kaysen,
GA.;
Acute--phase
response
predicts
erythropoietin
resistance
in
hemodialysis
and
peritoneal
dialysis
patients.
Am.
J.
Kidney.
Dis.
33,
63--72(1999).
20.
Kalantar--Zadeh,
K.;
Kopple,
JD.;
Block,
G.;
Humphreys,
MH.;
A
malnutrition--inflammation
score
is
correlated
with
morbidity
and
mortality
in
maintenance
hemodialysis
patients.
Am.
J.
Kidney
Dis.38,
1251--1263(2001).
21.
Kalantar--Zadeh,
K.;
Kopple,
JD.;
Humphreys,
MH.;
Block,
G.;
Comparing
outcome
predictability
of
markers
of
malnutrition--inflammation
complex
syndrome
in
haemodialysis
patients.
Nephrol.
Dial.
Transplant.19,
1507--19
(2004).
22.
Demir,
M.;
Kucuk,
A.,
Sezer,
MT.;
Altuntas,
A.,
Kaya,
S.;
Malnutrition--inflammation
score
and
endothelial
dysfunction
in
hemodialysis
patients.
J.
Ren.
Nutr.20,
377--383
(2010).
23.
Rambod,
M.;
Bross,
R.;
Zitterkoph,
J.;
Benner,
D.;
Pithia,
J.;
Colman,
S.;
et
al.
Association
of
Malnutrition--Inflammation
Score
with
quality
of
life
and
mortality
in
hemodialysis
patients:
a
5--year
prospective
cohort
study.
Am.
J.
Kidney
Dis.53,
298--309
(2009).
24.
Kalantar--Zadeh,
K.;
Block,
G.;
McAllister,
CJ.;
Humphreys,
MH.;
Kopple,
JD.;
Appetite
and
inflammation,
nutrition,
anemia,
and
clinical
outcome
in
hemodialysis
patients.
Am.
J.
Clin.
Nutr.80,
299--307
(2004).
25.
Kalantar--Zadeh,
K.;
McAllister,
CJ.;
Lehn,
RS.;
Lee,
GH.;
Nissenson,
AR.;
Kopple,
JD.;
Effect
of
malnutrition--inflammation
complex
syndrome
on
EPO
hyporesponsiveness
in
maintenance
hemodialysis
patients.
Am.
J
Kidney
Dis.42,
761--773
(2003).
26.
Kalantar--Zadeh,
K.,
Lee,
GH.;Miller,
JE.;
Streja,
E.;
Jing,
J.;
Robertson,
JA.;
et
al.
Predictors
of
hyporesponsiveness
to
erythropoiesis--stimulating
agents
in
hemodialysis
patients.
Am.
J.
Kidney
Dis.53,
823--834
(2009).
27.
Ho,
LC.;
Wang,
HH.;
Peng,
YS.;
Chiang,
CK.;
Huang,
JW.;
Hung,
KY.;
et
al.
Clinical
utility
of
malnutrition--inflammation
score
in
maintenance
hemodialysis
patients:
focus
on
identifying
the
best
cut--off
point.
Am.
J.
Nephrol.
28,
840--846
(2008).
28.
Alastrue,
A.;
Valoración
de
los
parámetros
antropométricosen
nuestra
población.
Med.
Clin.
(Barc).78,
407--415
(1982).
29.
Chertow,
GM.;
Lazarus,
JM.;
Lew,
NL.;
Ma,
L.;
Lowrie,
EG.;
Bioimpedance
norms
for
the
hemodialysis
population.
Kidney.
Int.52,1617--1621
(1997).
30.
Kilpatrick,
RD.;
Critchlow,
CW.;
Fishbane,
S.;
Besarab,
A.;
Stehman--Breen,
C.;
Krishnan,
M.;
et
al.
Greater
epoetin
alfa
responsiveness
is
associated
with
improved
survival
in
hemodialysis
patients.
Clin.
J.
Am.
Soc.
Nephrol.3,
1077--1083
(2008).
31.
Jelkmann,
WE.;
Fandrey,
J.;
Frede,
S.;
Pagel,
H.;
Inhibition
of
erythropoietin
production
by
cytokines.
Implications
for
the
anemia
involved
in
inflammatory
states.
Ann.
NY
Acad.
Sci.15,
300--309
(1994).
553
